https://www.criteriuminc.com/news-blog/publication/safety-and-efficacy-of-carfilzomib-in-patients-with-previously-treated-systemic-light-chain-al-amyloidosis/ 2025-02-28T15:59:02+00:00 https://www.criteriuminc.com/news-blog/publication/safety-efficacy-of-tucatinib-letrozole-palbociclib-patients-with-previously-treated-hr-her2-breast-cancer/ 2025-02-28T16:02:22+00:00 https://www.criteriuminc.com/news-blog/publication/multicenter-retrospective-chart-review-clinical-outcomes-mutant-non-small-cell-lung-cancer/ 2025-02-28T16:05:28+00:00 https://www.criteriuminc.com/news-blog/publication/treatment-outcomes-in-alk-or-ros1-altered-nsclc/ 2025-02-28T16:05:44+00:00 https://www.criteriuminc.com/news-blog/publication/prospective-observational-study-revealing-early-pulmonary-function-changes-associated-with-brigatinib-initiation/ 2025-02-28T16:05:58+00:00 https://www.criteriuminc.com/news-blog/publication/the-activity-of-brigatinib-in-patients-with-disease-progression-after-second-generation-anaplastic-lymphoma-tyrosine-kinase-inhibitors-and-an-exploratory-analysis-of-circulating-tumor-dna/ 2025-02-28T16:06:04+00:00 https://www.criteriuminc.com/news-blog/publication/a-durable-complete-response-to-ceritinib-in-a-patient-with-ros1-mutated-early-onset-metastatic-colon-cancer/ 2025-02-28T16:06:14+00:00 https://www.criteriuminc.com/news-blog/publication/a-phase-ii-study-investigating-cabozantinib-in-patients-with-refractory-metastatic-colorectal-cancer/ 2025-02-28T16:06:39+00:00 https://www.criteriuminc.com/news-blog/publication/phase-ii-study-of-selumetinib-plus-irinotecan-as-second-line-therapy-in-patients-with-k-ras-mutated-colorectal-cancer/ 2025-02-28T16:06:45+00:00 https://www.criteriuminc.com/news-blog/publication/carfilzomib-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-myeloma/ 2025-02-28T16:06:51+00:00 https://www.criteriuminc.com/news-blog/publication/study-of-the-oxphos-inhibitor-me-344-with-bevacizumab-in-refractory-metastatic-colorectal-cancer/ 2025-03-11T13:25:16+00:00 https://www.criteriuminc.com/news-blog/publication/long-term-outcomes-of-radiation-monotherapy-versus-combined-radiation-monotherapy/ 2026-04-17T11:51:52+00:00 https://www.criteriuminc.com/news-blog/publication/response-of-leptomeningeal-metastasis-of-breast-cancer-with-a-her2-neu-activating-variant-to-tucatinib-a-case-report/ 2026-06-08T19:30:18+00:00 https://www.criteriuminc.com/news-blog/publication/trastuzumab-therapy-duration-in-her2-positive-de-novo-metastatic-breast-cancer/ 2026-06-08T19:35:07+00:00 https://www.criteriuminc.com/news-blog/publication/brigatinib-versus-crizotinib-in-alk-positive-non-small-cell-lung-cancer/ 2026-06-08T19:38:24+00:00 https://www.criteriuminc.com/news-blog/publication/development-review-and-activation-of-thoracic-oncology-investigator-initiated-trials/ 2026-06-08T19:43:49+00:00 https://www.criteriuminc.com/news-blog/publication/phase-ii-clinical-trial-and-preclinical-evaluation-of-a-novel-cd47-blockade-combination/ 2026-08-19T18:06:13+00:00